Br-IQ-17-B

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBr-IQ-17-B
Drug Alias NameBr-IQ17BBr-IQ-17-B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit agonists
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsSchizophreniaCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHong Kong University Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesHong Kong University Of Science And Technology
Inactive CompaniesN/A
Active IndicationsSchizophreniaCognition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A